Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 4 studies | 21% ± 4% |
Insufficient scRNA-seq data for expression of ZNF473 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 509.11 | 459 / 459 | 99% | 7.64 | 1112 / 1118 |
bladder | 100% | 556.19 | 21 / 21 | 99% | 6.20 | 500 / 504 |
uterus | 100% | 601.11 | 170 / 170 | 99% | 7.80 | 454 / 459 |
prostate | 100% | 771.78 | 245 / 245 | 99% | 10.09 | 496 / 502 |
stomach | 100% | 392.79 | 359 / 359 | 98% | 6.69 | 281 / 286 |
thymus | 100% | 687.92 | 653 / 653 | 98% | 4.94 | 594 / 605 |
brain | 99% | 448.32 | 2610 / 2642 | 99% | 6.11 | 700 / 705 |
lung | 100% | 596.09 | 576 / 578 | 98% | 5.79 | 1135 / 1155 |
esophagus | 100% | 456.10 | 1445 / 1445 | 98% | 6.73 | 179 / 183 |
intestine | 100% | 489.30 | 966 / 966 | 98% | 6.14 | 515 / 527 |
ovary | 100% | 518.10 | 180 / 180 | 98% | 6.74 | 420 / 430 |
skin | 100% | 495.43 | 1808 / 1809 | 97% | 6.96 | 460 / 472 |
pancreas | 99% | 344.56 | 326 / 328 | 97% | 4.71 | 172 / 178 |
adrenal gland | 100% | 493.31 | 258 / 258 | 92% | 4.60 | 211 / 230 |
kidney | 100% | 479.90 | 89 / 89 | 88% | 3.86 | 791 / 901 |
liver | 100% | 336.38 | 226 / 226 | 71% | 2.84 | 289 / 406 |
adipose | 100% | 488.60 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 1018.45 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 8.36 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.11 | 1 / 1 |
blood vessel | 99% | 351.57 | 1327 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 372.27 | 796 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 5.08 | 28 / 29 |
heart | 96% | 233.11 | 829 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 86% | 3.45 | 69 / 80 |
peripheral blood | 79% | 304.70 | 732 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006398 | Biological process | mRNA 3'-end processing by stem-loop binding and cleavage |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0015030 | Cellular component | Cajal body |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ZNF473 |
Protein name | Zinc finger protein 473 (Zinc finger protein 100 homolog) (Zfp-100) Zinc finger protein 473 |
Synonyms | KIAA1141 ZFP100 |
Description | FUNCTION: Involved in histone 3'-end pre-mRNA processing by associating with U7 snRNP and interacting with SLBP/pre-mRNA complex. Increases histone 3'-end pre-mRNA processing but has no effect on U7 snRNP levels, when overexpressed. Required for cell cycle progression from G1 to S phases. . |
Accessions | Q8WTR7 ENST00000270617.8 ENST00000594968.1 ENST00000595661.5 M0R032 ENST00000391821.6 ENST00000598809.5 M0R2N2 M0QZY7 M0R123 ENST00000599155.1 F8WEC7 ENST00000601364.5 ENST00000445728.7 |